We are experienced. We are curious. We are problem solvers.
At Arrivo, we strive to set a new standard in drug development that starts with the selection of drug candidates and runs throughout clinical development. Our approach and decision-making has delivered a history of excellent returns and product successes that makes us the trusted partner for industry and investors.
Working in partnership with investors, innovators, and pharmaceutical companies, Arrivo is always seeking out solutions for unmet medical needs. We strive to be the new standard for strategic asset selection and develop novel products through process that is both highly efficient and thoughtful.
Our model allows the company to look for potential products that offer improvements in patient care across many different therapeutic areas. We can be opportunistic, and not tied to a particular disease or disorder, because we do not have to worry about the product fitting into our commercial infrastructure. Instead, we find the right commercial partner for each individual product. This flexibility has enabled us to build a pipeline of diverse assets with a common theme, all of our programs address unmet medical needs of patients and all have the potential to be first-in-class or best-in-class.